drugset / Trial / NCT05313750
Efficacy and Safety of Sitafloxacin in the Treatment of Acute Exacerbation of Bronchiectasis in Adults
RandomizedParallel-groupOpen-labelTreatment
Summary
The treatment of acute exacerbation of bronchiectasis requires comprehensive treatment, and antibacterial drug therapy is the key. The study is a multicenter, randomized, evaluator-blinded, levofloxacin parallel-controlled clinical study designed to evaluate the efficacy and safety of sitafloxacin in the treatment of acute exacerbations of bronchiectasis in adults.
Timeline
- Start
- 2021-06-30
- Primary completion
- 2023-12-30
- Completion
- 2024-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Levofloxacin | Small molecule | 0.4 g | Oral |
| Subject | SITAFLOXACIN ANHYDROUS | Small molecule | 0.1 g | Oral |